| 1. |
Vande J.B. Gaston E.A.,and Dawber T.R.(1968) The significance of nontoxic nodules: final report of a 15-year study of the
incidence of thyroid malignancy.Ann.Intern.Med.
69, 537–540.
|
| |
| 2. |
Mazzaferri E. L. (1992) Thyroid cancer in thyroid nodules: finding a needle in the haystack. Am. J. Med.
93, 359–362.
<Occurrence Type="DOI"><Handle>10.1016/0002-9343(92)90163-6</Handle></Occurrence>
|
| |
| 3. |
Rosai, J. (1996) Thyroid gland, in Ackerman’s Surgical Pathology, Mosby, St. Louis, MO, pp. 493–567.
|
| |
| 4. |
Andreoli, T.E. Carpenter, C.C.J. Bennett, J.C.and Plum, F.(1997) The thyroid gland, in Cecil Essentials of Medicine, W.B.Saunders, Philadelphia, pp.487–496.
|
| |
| 5. |
Rosai, J., Carcangiu M. L., and Delellis, R. A. (1992) Tumors of the thyroid gland, in Atlas of Tumor Pathology, Third Series, Fascicle 5, Armed Forces Institute of Pathology, Washington, DC.
|
| |
| 6. |
Grieco, M., Santoro, M., Berlingieri, M. T., et al. (1990) PTC is a novel rearranged form of the ret proto-oncogene and is
frequently detected in vivo in human thyroid papillary carcinomas.Cell
60, 557–563.
<Occurrence Type="DOI"><Handle>10.1016/0092-8674(90)90659-3</Handle></Occurrence>
|
| |
| 7. |
Santoro, M., Sabino, N., Ishizaka, Y., et al. (1993) Involvement of RET oncogene in human tumors: specificity of RET activation
to thyroid tumors. Br. J. Cancer
68,460–464.
|
| |
| 8. |
Santoro, M., Dathan, N. A., Berlingeri, M. T., et al. (1994) Molecular characteristics or RET/PTC3: a novel rearranged version
of the RET protooncogene in a human thyroid papillary carcinoma. Oncogene
9, 509–516.
|
| |
| 9. |
Fusco, A., Chiapetta, G., Hui, P., et al. (2002) Assessment of RET/PTC oncogene activation and clonality in thyroid nodules
with incomplete morphological evidence of papillary carcinoma-A search for the early precursor of papillary cancer.Am.J.Path.
160, 2157–2167.
|
| |
| 10. |
Greene, F.L., Page, D.L., Fleming, I.D., et al. (2002) AJCC Cancer Staging Manual, 6th edition. Springer-Verlag, New York, pp.77–87.
|
| |
| 11. |
Williams, E. D. (2000) Guest editorial: two proposals regarding the terminology of thyroid tumors. Internat. J. Surg. Pathol.
8,181–183.
|
| |
| 12. |
Izzo, P., Costanzo, P., Lupo, A., et al. (1987) A new human species of aldolase A mRNA from fibroblasts. Eur. J. Biochem.
164, 9–13.
|
| |
| 13. |
Viglietto, G., Chiappetta, G., Fukunaga, et al. (1995) RET/PTC oncogene activation is an early event in thyroid carcinogenesis.
Oncogene
11,1207–1210.
|
| |
| 14. |
Tallini, G., Santoro, M., Helie, M., et al. (1998) RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas
lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. Clin. Cancer Res.
4, 287–294.
|
| |
| 15. |
Huang, L. E., Luzzi, V., Ehrig, T., Holtschlag, V., and Watson, M. A. (2002) Optimized tissue processing and staining for
laser capture microdissection and nucleic acid retrieval. Methods Enzymol.
356, 49–62.
|
| |
| 16. |
Fend, F., Specht, K., Kremer, M., and Quintanilla-Martinez, L. (2002) Laser capture microdissection in pathology. Methods Enzymol.
356, 196–206.
|
| |
| 17. |
Sheehan, D. C. and Hrapchak, B. B. (1980) Theory and Practice of Histotechnology, Battle Press, Columbus, OH, 2nd edition 1980, p. 151.
|
| |
| 18. |
Goldsworthy, S. M., Stockton, P. S., Trempus, C. S., Foley, J. F., and Maronpot, R. R. (1999) Effects of fixation on RNA extraction
and amplification from laser capture microdissected tissue. Mol. Carcinog.
25, 86–91.
<Occurrence Type="DOI"><Handle>10.1002/(SICI)1098-2744(199906)25:2<86::AID-MC2>3.0.CO;2-4</Handle></Occurrence>
|
| |